Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer
2024 · Journal of Translational Medicine · 8 citations
https://doi.org/10.1186/s12967-023-04675-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
9
Citations
1
h-index
0
i10-index
Haiteng Zeng is an academic researcher from Key Laboratory of Guangdong Province. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 1, co-authored 2 publications.
Click to start Chat